000 | 01905 a2200517 4500 | ||
---|---|---|---|
005 | 20250514200145.0 | ||
264 | 0 | _c20040920 | |
008 | 200409s 0 0 eng d | ||
022 | _a0003-3022 | ||
024 | 7 |
_a10.1097/00000542-200409000-00022 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKharasch, Evan D | |
245 | 0 | 0 |
_aInfluence of hepatic and intestinal cytochrome P4503A activity on the acute disposition and effects of oral transmucosal fentanyl citrate. _h[electronic resource] |
260 |
_bAnesthesiology _cSep 2004 |
||
300 |
_a729-37 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnalgesics, Opioid _xadministration & dosage |
650 | 0 | 4 |
_aAntibiotics, Antitubercular _xpharmacology |
650 | 0 | 4 |
_aAntiemetics _xpharmacology |
650 | 0 | 4 | _aArea Under Curve |
650 | 0 | 4 |
_aAryl Hydrocarbon Hydroxylases _xmetabolism |
650 | 0 | 4 | _aBeverages |
650 | 0 | 4 | _aChromatography, High Pressure Liquid |
650 | 0 | 4 | _aCitrus |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 | _aCytochrome P-450 CYP3A |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFentanyl _xadministration & dosage |
650 | 0 | 4 | _aFood-Drug Interactions |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntestines _xenzymology |
650 | 0 | 4 |
_aLiver _xenzymology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aOxidoreductases, N-Demethylating _xmetabolism |
650 | 0 | 4 |
_aPupil _xdrug effects |
650 | 0 | 4 |
_aRifampin _xpharmacology |
650 | 0 | 4 | _aSpectrometry, Mass, Electrospray Ionization |
650 | 0 | 4 |
_aTroleandomycin _xpharmacology |
700 | 1 | _aWhittington, Dale | |
700 | 1 | _aHoffer, Christine | |
773 | 0 |
_tAnesthesiology _gvol. 101 _gno. 3 _gp. 729-37 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00000542-200409000-00022 _zAvailable from publisher's website |
999 |
_c15027303 _d15027303 |